Glioma-bearing rat are intracranially injected with 2 nM modified AED-1/MTDH siRNA-1 and AED-1/MTDH siRNA-2 seven days after initial tumor cell injection once every other day for two weeks (n = 5 per group). The gene discussed is MTDH; the disease is neoplasm.